People: Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

1:30am IST
Change (% chg)

$1.80 (+2.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Russell, Lesley 

Dr. Lesley Russell, MBChB, MRCP, is an Independent Director of the company. Dr. Russell is currently Chief Medical Officer of Innocoll Holdings Plc., a public biotechnology company, which she joined in April 2016. Dr. Russell previously served as Chief Operating Officer and Chief Medical Officer of TetraLogic Pharmaceuticals, another public biotechnology company, from August 2013, and prior to that during 2013 she operated as an independent consultant. Dr. Russell was a medical executive with Cephalon, Inc. from January 2000 to 2011, most recently as Executive Vice President and Chief Medical Officer from September 2006 until October 2011, when Cephalon was acquired by Teva Pharmaceuticals. Dr. Russell served as a Senior Vice President and Global Head, Research and Development for Global Branded Products from the acquisition until July 2012. Dr. Russell previously held positions in medical research at US Bioscience, Eli Lilly and Amgen. Dr. Russell serves as an independent director of AMAG Pharmaceuticals, Inc., a public specialty pharmaceutical company, and Endocyte Pharmaceuticals, Inc., a public biotechnology company. Dr. Russell holds a Bachelor of Medicine, Bachelor of Surgery (MBChB) from the University of Edinburgh and is a member of the Royal College of Physicians, UK.

Basic Compensation

Total Annual Compensation, USD 55,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 306,690
Fiscal Year Total, USD 361,690

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bruce Carter


Jay Luly


Paul Mellett


Yat Sun Or


Nathaniel Gardiner


Nathalie Adda

As Of  30 Sep 2018